EQT to Acquire QIAGEN in 10.8 Billion Euro All-Cash Deal

Key Facts

1Private equity firm EQT announced the acquisition of QIAGEN in an all-cash deal.

2The total value of the acquisition deal is 10.8 billion euros.

Private equity firm EQT announced the acquisition of QIAGEN in an all-cash deal. Investing.com reported that the total value of the acquisition is 10.8 billion euros, following a definitive agreement reached between the two parties.

The deal follows previously reported advanced acquisition talks and represents a major consolidation within the life sciences and diagnostics sector. The transaction provides a definitive exit price for shareholders amid ongoing M&A activity in the healthcare industry.